Phase I/II trial of radioimmunotherapy with 131Iodine labeled A5B7 anti-CEA antibody [monoclonal antibody A5B7 I-131] in combination with CA4P for advanced colorectal cancer and advanced gastrointestinal carcinoma

Trial Profile

Phase I/II trial of radioimmunotherapy with 131Iodine labeled A5B7 anti-CEA antibody [monoclonal antibody A5B7 I-131] in combination with CA4P for advanced colorectal cancer and advanced gastrointestinal carcinoma

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 30 Mar 2006

At a glance

  • Drugs Fosbretabulin; Monoclonal antibody A5B7 I-131
  • Indications Colorectal cancer; Gastrointestinal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Mateon Therapeutics
  • Most Recent Events

    • 30 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top